Targeting the ADAM17 pathway presents a therapeutic target for fibrosis or cancer.46, 47, 48, 49, 50 However, reports have not indicated the involvement of ADAM17 upstream regulators, such as miRNA, in the regulation of the ADAM17 pathway. The gene discussed is ADAM17; the disease is cancer.